The EVAR Center

Filter Your Results

 

News

 

Study in The Netherlands Evaluates Risks of EVAR in Large-Diameter Necks

January 18, 2017 -- In order to determine the impact of infrarenal neck diameter on midterm outcomes following endovascular aneurysm repair (EVAR) with a single stent graft wi…

Endologix Resumes Shipments of All Sizes of AFX2 Endovascular AAA Systems

January 17, 2017 -- Endologix, Inc. announced that the company has resumed shipments of all sizes of AFX2 endovascular abdominal aortic aneurysm (AAA) systems. The large diame…

Benefits of Multispecialty Vascular Care Teams

Misaki Kiguchi, MD, MBA, MSc, RPVI; John S. Steinberg, DPM, FACFAS; Christian C. Shults, MD; and Edward Y. Woo, MD

January 2017—Combining resources across service lines to bring patients more comprehensive treatment options for complex aortic disease and critical limb ischemia.

Aortic Emergency: A Team Approach

Manish Mehta, MD, MPH

January 2017—One institution’s experience in establishing a systematic, standardized, protocol-driven approach to management of ruptured abdominal aortic aneurysms.

Study Finds No Effect of Statin Therapy on Aneurysm Sac Regression After EVAR

January 11, 2017 -- In a study by Wonho Kim, MD, et al published in the Journal of Vascular and Interventional Radiology (JVIR; 2017;28:35 -- 43), statin therap…

Lombard Medical's IntelliFlex LP Delivery System for the Aorfix EVAR System Approved in Japan

January 5, 2017 -- Lombard Medical, Inc. announced approval from the Japanese Ministry of Health, Labor, and Welfare for its IntelliFlex LP low-profile delivery system for use…

Endologix Resumes Shipping for All AFX and Most AFX2 Devices

UPDATE: December 29, 2016 -- Endologix, Inc. announced that based on positive testing results, it has removed the temporary shipping hold on all sizes of its AFX Endovascular…

Endologix's AFX2 Bifurcated Endograft System Approved in Australia

December 19, 2016 -- Endologix, Inc. announced that the Australian Therapeutic Goods Administration has approved the AFX2 bifurcated endograft system for endovascula…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.